Bard v. Boston Scientific
This article was originally published in The Gray Sheet
Executive Summary
Bard receives $13.3 mil. in damages following court-of-appeals decision on patent infringement concerning company's Elimination dilation catheters. Boston Scientific had appealed a 1997 jury decision, which found that its Maxforce esophageal dilation balloon catheter infringed on Bard's patent. Boston Scientific notes that the Maxforce has not been sold for several years, and that the $13.3 mil. payment "will have no material financial statement impact"